Ruthenium antimicrobial compounds - an alternative to traditional antimicrobials

Tue23  Feb10:20am(20 mins)
Conference Room 1
Miss Kirsty Smitten


Two lead, ruthenium antimicrobial compounds have been developed. The compounds exhibit comparable activities to clinically available antibiotics and retain this high activity in extensively-drug resistant strains. The high efficacy and low mammalian toxicity of the compounds has been demonstrated in vitro and in vivo. The compounds have been validated in the marketplace and, given the strong preclinical data, their further development has been funded through the formation of a new spin-out company.
To view the video assoicated with this lecture click here

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021